SCHEMBL19485602

SCHEMBL19485602

CC(C)(C)c1ccc(C(=O)N[C@@H](Cc2ccc(-c3ncc(-c4ccc(C5CCCC5)cc4)cn3)cc2)C(=O)N2CC[C@H](C(=O)O)C2)s1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 1/20 0.38
▸ S1PR4 O95977 3/20 0.36
▸ S1PR1 P21453 3/20 0.36
▸ S1PR5 Q9H228 3/20 0.36
▸ S1PR3 Q99500 2/20 0.36
▸ CCR1 P32246 3/20 0.36
▸ ACKR3 P25106 1/20 0.35
▸ F10 P00742 4/20 0.35
▸ PLG P00747 4/20 0.35
▸ PLAU P00749 4/20 0.35
▸ F2 P00734 3/20 0.35
▸ ST14 Q9Y5Y6 3/20 0.35
▸ KMT2A Q03164 2/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ KDM1A O60341 1/20 0.34
▸ ITGB3 P05106 1/20 0.33
▸ ITGA2B P08514 1/20 0.33
▸ CALCA P06881 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17834771 0.95 S1PR1 (0.39) PRCPS1PR4S1PR1S1PR5S1PR3
SCHEMBL17834847 0.93 CCR1 (0.36) PRCPS1PR1S1PR5CCR1F10
SCHEMBL16306082 0.93 PRCP (0.42) PRCPACKR3F10PLGPLAU
SCHEMBL16343137 0.91 ITGB3 (0.41) PRCPACKR3F10PLGPLAU
SCHEMBL16295288 0.91 ITGB3 (0.41) PRCPACKR3F10PLGPLAU
SCHEMBL16305725 0.91 PRCP (0.38) PRCPS1PR4S1PR1S1PR5S1PR3
SCHEMBL22167263 0.91 S1PR4 (0.38) PRCPS1PR4S1PR1S1PR5S1PR3
SCHEMBL17834650 0.89 S1PR1 (0.35) PRCPS1PR4S1PR1S1PR5S1PR3
SCHEMBL17834844 0.89 S1PR1 (0.35) PRCPS1PR4S1PR1S1PR5S1PR3
SCHEMBL17834841 0.89 S1PR1 (0.35) PRCPS1PR4S1PR1S1PR5S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2018-01-25 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PRCP 600/4885S1PR4 665/4885S1PR1 486/4885
US-10034886-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR PRCP 775/4885S1PR4 713/4885S1PR1 523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback